US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist
  • 27.110
  • +1.320+5.12%
Close May 8 16:00 ET
  • 27.110
  • 0.0000.00%
Post 16:05 ET
1.59BMarket Cap10.67P/E (TTM)

Protagonist Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Protagonist Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

60.00M

0.00%
EPS(YoY)

0.44

+163.77%
Analyst Rating

Strong Buy

May 8, 2024

Protagonist Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q1254.953M / 120.000M--
--2023/Q460.000M / 30.000M--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 1.667M--
--2022/Q40.000 / 5.000M--
--2022/Q30.000 / 0.000--
--2022/Q2859.000K / 383.330K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q1254.953M / 120.000M--
--2023/Q460.000M / 30.000M--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 1.667M--
--2022/Q40.000 / 5.000M--
--2022/Q30.000 / 0.000--
--2022/Q2859.000K / 383.330K--

Unlock Free Earnings Estimates

Protagonist Therapeutics Earnings Reports

  • Protagonist Therapeutics | 10-Q: Quarterly report

    May 7 16:59 ET

  • Protagonist Therapeutics | 10-K: Annual report

    Feb 27 22:39 ET

  • Protagonist Therapeutics: Q3 2023 Earnings Report

    Nov 2, 2023 17:07 ET

  • Protagonist Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 3, 2023 16:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 8, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg